Learning Objectives

1.Describe the two distinct etiologies of MCC and how they both result in an ‘immunogenic cancer’

2.Identify risk factors that affect decision making for surgical margin size and adjuvant radiation therapy, and choose appropriate therapeutic options for advanced MCC

Session date: 
01/10/2023 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Paul Nghiem, MD, PhD